Chan et al. demonstrated mice lacking adaptive immune cells and ILCs (RAG2-/-IL-2Rγc-/-) to be resistant to tumor formation triggered by IL-23, whereas tumor development did not differ between RAG1-/- and wild-type mice40. The gene discussed is IL23A; the disease is neoplasm.